⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
newsfilecorp.com
MLTX
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
newsfilecorp.com
MLTX
MoonLake Immunotherapeutics (MLTX) Class Action Deadline December 15 - Investors Notified to Contact BFA Law to Protect Your Rights
accessnewswire.com
MLTX
DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions
globenewswire.com
ATYR
MLTX
BAX
JHX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
globenewswire.com
MLTX
INVESTOR REMINDER: Important MoonLake Immunotherapeutics Securities Class Action Deadline Approaching on December 15 for Investors with Losses – Contact BFA Law
globenewswire.com
MLTX
Bragar Eagel & Squire, P.C. Urges Investors of aTyr, Marex, Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines
globenewswire.com
ATYR
MRX
MLTX
CPTN
MoonLake Immunotherapeutics’ (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman
globenewswire.com
MLTX
Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Recover Losses - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Investors in MoonLake Immunotherapeutics Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights – MLTX
globenewswire.com
MLTX